For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Nexell Therapeutics Inc.

USPTO Granted Patents = 10

Forward Citations = 164

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Dennis E Van Epps (7 out of 10 patents)

James G Bender (6 out of 10 patents)

Stephen L Smith (6 out of 10 patents)

4. Kristen L Unverzagt (3 out of 5 patents)

5. Phillip B Maples (3 out of 4 patents)

6. Maureen F Loudovaris (3 out of 3 patents)

7. Susan M Maciukas (3 out of 3 patents)

8. Xiaoying Qiao (3 out of 3 patents)

9. Sam L Helgerson (2 out of 8 patents)

10. Robert J Deans (2 out of 2 patents)

11. Roy Guillermo (2 out of 2 patents)

12. Fahad A Al-Abdaly (2 out of 2 patents)

13. Joan A Kobori (2 out of 2 patents)

14. Janet Tseng-Law (2 out of 2 patents)

15. Mona Vachula (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 6458585 - Cytokine-free culture of dendritic cells (2002-10-01),

2. 6251295 - Method for recirculation washing of blood cells (2001-06-26),

3. 6146623 - In vitro-derived genetically altered human neutrophil precursor cells (2000-11-14),

4. 6037174 - Preparation of serum-free suspensions of human hematopoietic cells or (2000-03-14),

5. 6017719 - Positive and positive/negative cell selection mediated by peptide release (2000-01-25),

6. 6010697 - Infusion of neutrophil precursors for treatment of neutropenia (2000-01-04),

7. 5968753 - Positive and positive/negative cell selection mediated by peptide release (1999-10-19),

8. 5955357 - In-vitro-derived human neutrophil precursor cells (1999-09-21),

9. 5888499 - Method for increasing neutrophil populations using in vitro-derived (1999-03-30),

10. 5846529 - Infusion of neutrophil precursors for treatment of neutropenia (1998-12-08),

Nexell Therapeutics Inc. is a biotechnology company focused on developing novel cell-based therapies for various diseases. With a diverse pipeline of innovative treatments, Nexell Therapeutics is dedicated to advancing personalized medicine and improving patient outcomes. The company's cutting-edge research and development efforts aim to revolutionize the field of regenerative medicine and redefine the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#280 in Irvine, CA

#6,897 in California

#29,016 in US

#54,349 in the World

Irvine, CA, United States of America

Nexell Therapeutics Inc.

Forward Citations = 164

18 inventors:

Dennis E Van Epps (7 out of 10 patents)

James G Bender (6 out of 10 patents)

Stephen L Smith (6 out of 10 patents)

4. Kristen L Unverzagt (3 out of 5 patents)

5. Phillip B Maples (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…